Table 3. Hazard ratios for relapse free survival comparing cyclophosphamide, epirubicin and fluorouracil (CEF) with cyclophosphamide, epirubicin and paclitaxel (EC/T) by biomarker status.

	Relapse Free Survival
	Low Biomarker		High Biomarker		Treatment*Marker
	HR	95% CI	HR	95% CI	HR	Test for Interaction P
CIN70	1.30	0.76-2.21	0.79	0.51-1.23	1.43	0.355
CIN25	1.35	0.78-2.34	0.78	0.51-1.20	1.57	0.263
CIN4	0.64	0.39-1.03	1.53	0.91-2.57	0.49	0.066